Auto saved by Logseq

master
Borja Robert 12 months ago
parent 06bce58711
commit a1ddc393a7

@ -49,4 +49,8 @@ date:: [[2023/12]]
- Full draft protocol Q1 2024 (after formative research) - Full draft protocol Q1 2024 (after formative research)
- 3 dose regimen - 3 dose regimen
- Continue to include potential to inform future MDA design and improved effectiveness/cost effectiveness of MDAs, improved clinical management - Continue to include potential to inform future MDA design and improved effectiveness/cost effectiveness of MDAs, improved clinical management
- Alejandro to share potential protocol/design for salivary testing of [[Albendazol]] (e.g. 48 hours after dose 3) to complement - Alejandro to share potential protocol/design for salivary testing of [[Albendazol]] (e.g. 48 hours after dose 3) to complement reported coverage data.
- Economics Contributes also to WP3 (KEMRI)
- GHS RDD to consider options for inclusion of key costing data points
- Discuss with GHS economist
- Discuss with KEMRI (e.)
Loading…
Cancel
Save